Cayuga Biotech develops hemostatic drugs and devices for treating bleeding episodes.
Business Model:
Revenue: $0
Employees: 11-50
Address: -
City: New York City
State: NY
Zip: 10162
Country: US
Cayuga Biotech is a startup developing novel hemostatic drugs and devices to reduce uncontrollable bleeding which is a leading cause of death from traumatic injuries. The company&s;s polyphosphate-based drug accelerates the body&s;s own clotting process to contain clotting at the injury site and thus minimize the risk of side effects. Cayuga is developing drugs for indications that treat traumatic hemorrhage as well as rare bleeding disorders.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2020 | Seed Round | 2 | $250k |
IndieBio SOSV IndieBio SOSV |
1/2022 | Seed Round | 2 | - |
IndieBio SOSV IndieBio SOSV |
11/2020 | Convertible Note | 2 | - |
IndieBio SOSV IndieBio SOSV |
1/2022 | Seed Round | 2 | - |
IndieBio SOSV IndieBio SOSV |
11/2020 | Convertible Note | 2 | - |
IndieBio SOSV IndieBio SOSV |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|